Fallahi‐Sichani, Mohammad https://orcid.org/0000-0003-0917-3525
Becker, Verena
Izar, Benjamin
Baker, Gregory J
Lin, Jia‐Ren
Boswell, Sarah A https://orcid.org/0000-0002-3118-3378
Shah, Parin https://orcid.org/0000-0002-7259-1810
Rotem, Asaf https://orcid.org/0000-0002-6859-7435
Garraway, Levi A
Sorger, Peter K https://orcid.org/0000-0002-3364-1838
Funding for this research was provided by:
National Institutes of Health (U54‐HL127365)
National Institutes of Health (CA139980)
National Institutes of Health (GM107618)
National Cancer Institute (K99CA194163)
Life Sciences Research Foundation
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Melanoma Research Alliance
Ludwig Center at Harvard
Dana‐Farber Cancer Institute
Article History
Received: 10 January 2016
Revised: 3 October 2016
Accepted: 26 November 2016
First Online: 9 January 2017
Conflict of interest
: LAG is a member of the scientific advisory board for Warp Drive, Inc., consultant for Novartis, Inc., and equity holder in Foundation Medicine, Inc. All other authors declare that they have no conflict of interest.